ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 525,64
0,30%
Dow Jones
38 495,62
-0,24%
DAX
18 026,18
0,03%
Brent Oil
82,875
0,91%
Bitcoin
65 335,53
-1,95%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Mainz BioMed NV (MYNZ)

  7. Mainz BioMed NV (MYNZ) Actualités

MYNZ Mainz BioMed NV

0,62
-0,005 (-0,80%)
Dernière mise à jour : 15:51:24
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Mainz BioMed NV MYNZ NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,005 -0,80% 0,62 15:51:24
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,6248 0,6176 0,639 0,625
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
03/6/202414:01GLOBEMainz Biomed Presented Industry Leading Results of its..
31/5/202423:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/5/202423:01GLOBEMainz Biomed Reports Results of 2024 Annual General Meeting
28/5/202414:01GLOBEMainz Biomed to Present New Pooled Colorectal Cancer..
20/5/202414:01GLOBEMainz Biomed Awarded Poster of Distinction at Digestive..
10/5/202423:20EDGAR2Form D/A - Notice of Exempt Offering of Securities: [Amend]
07/5/202414:01GLOBEMainz Biomed to Present Results of Colorectal Cancer..
25/4/202415:29GLOBEMainz Biomed Reports Positive Topline Results from Pooled..
09/4/202414:01GLOBEMainz Biomed Reports Full Year 2023 Financial Results
19/3/202413:01GLOBEMainz Biomed Organizes HALLO DOC! Event to Highlight..
18/3/202413:01GLOBEMainz Biomed: Webinar on Early Detection of Colorectal..
12/3/202413:01GLOBEMainz Biomed Presents ColoAlert® at UDH Congress 2024:..
05/3/202414:01GLOBEMainz Biomed Partners with Trusted Health Advisors to..
27/2/202414:01GLOBEMainz Biomed to Showcase at the Gynecology Conference in..
22/2/202414:01GLOBEMainz Biomed Announces Distribution Partnership with..
21/2/202414:01GLOBEMainz Biomed Establishes Strategic Partnership with TomaLab..
06/2/202414:01GLOBEMainz Biomed Establishes Physician-Led Laboratory Expanding..
11/1/202414:01GLOBEMainz Biomed and TestDNA Drive CRC Innovation at the 10th..
09/1/202414:01GLOBEMainz Biomed Provides Year-End Corporate Review 2023
19/12/202314:01GLOBEMainz Biomed and Bantleon Partner to Elevate Corporate..
12/12/202314:01GLOBEMainz Biomed Showcases ColoAlert® at Two Prominent..
05/12/202315:01GLOBEMainz Biomed Reports Positive Topline Results from U.S...
29/11/202314:01GLOBEMainz Biomed’s Presentation at the 35th Annual Piper Sandler..
20/11/202314:01GLOBEMainz Biomed to Present at the 35th Annual Piper Sandler..
16/11/202314:01GLOBEMainz Biomed Reports Third Quarter 2023 Financial Results..
15/11/202315:01GLOBEMainz Biomed Announces Closing of $5.0 million Registered..
13/11/202315:00GLOBEMainz Biomed Announces Pricing of $5.0 million Registered..
09/11/202314:01GLOBEMainz Biomed Partners with Liquid Biosciences to Harness the..
07/11/202314:01GLOBEMainz Biomed to Showcase ColoAlert® at Leading Global..
31/10/202313:01GLOBEMainz Biomed Reports Success from Employee Colorectal Cancer..
26/10/202314:01GLOBEMainz Biomed Appoints Tarrin Khairi-Taraki as VP of..
18/10/202314:01GLOBEMainz Biomed Presents Groundbreaking Results of ColoFuture..
11/10/202314:01GLOBEMainz Biomed to Showcase ColoAlert® at UEG Week 2023 in..
05/10/202314:01GLOBEMainz Biomed to Attend the JonesTrading 2023 Healthcare..
04/10/202314:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
27/9/202314:01GLOBEMainz Biomed to Present Detailed Results of ColoFuture Study..
20/9/202309:01GLOBEMainz Biomed to Present at the Cantor Fitzgerald Global..
13/9/202309:01GLOBEMainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA..
05/9/202309:01GLOBEMainz Biomed Announces Strategic Partnership with Ärztliches..
29/8/202309:01GLOBEMainz Biomed to Present at the H.C. Wainwright Global..
22/8/202309:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
15/8/202312:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202309:01GLOBEMainz Biomed Announces Financial Half Year Results 2023 and..
01/8/202309:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
18/7/202309:01GLOBEMainz Biomed Announces Collaboration with Fugene Genetics in..
11/7/202322:35EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/6/202309:01GLOBEMainz Biomed Secures up to $50M in New Funding
28/6/202322:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/6/202322:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/6/202309:01GLOBEMainz Biomed to Attend ESMO World Congress on..

Dernières Valeurs Consultées

NASDAQ
MYNZ
Mainz BioMed NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés